DeepBio MF

DeepBio MF specializes in in vitro diagnostic (IVD) devices, specifically those related to prostate health. Their portfolio includes products like the DeepDx Prostate and DeepDx Connect - Prostate, which are designed for diagnostic imaging and analysis. These devices are intended to aid in the early detection or monitoring of prostate-related conditions.

DeepBio MF is based in South Korea. While the company develops IVD devices, its products are registered in the EU’s euamed database, indicating compliance with European regulatory requirements for diagnostic medical devices. This registration reflects the company’s efforts to meet EU standards for market access, though it does not imply individual device approval.

DeepBio MF’s devices fall under the IVD General class in the EU regulatory framework. This classification applies to in vitro diagnostics that pose minimal risk, such as those used for routine testing or monitoring. The classification determines the regulatory pathway and documentation requirements for market placement, ensuring patient safety and device performance.

DeepBio MF’s devices are listed in the euamed database, which is the official EU registry for medical devices. This registry provides transparency on manufacturers, their devices, and their regulatory status within the European market. Listing in euamed is a requirement for IVD devices seeking compliance with EU regulations.